Niquitin

---

title: "Niquitin" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["smoking-cessation", "haleon-brands"] description: "Range of nicotine replacement products" topic_path: "general/smoking-cessation" source: "https://en.wikipedia.org/wiki/Niquitin" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Range of nicotine replacement products ::

NiQuitin is a range of nicotine replacement products designed to help smokers quit by replacing the nicotine supplied by cigarettes with a lower, steadier level in order to relieve withdrawal. This is to help users wean off nicotine gradually. Nicotine replacement therapy products (e.g. chewing gum, lozenges, transdermal systems) are indicated as temporary aids for cigarette smokers who want to give up smoking. They serve as alternative sources of nicotine and provide relief of nicotine withdrawal symptoms in nicotine-dependent individuals who are acutely withdrawing from cigarette smoking.

History

Created by GlaxoSmithKline, NiQuitin was approved by the FDA in 1991, one of the earliest products brought to market to provide an alternative to the withdrawal symptoms of quitting smoking. Nicotine gums were already widely used among consumers.

The product is sold globally under different brand names such as Nicoderm in the US, Nicabate in Australia and New Zealand and NiQuitin CQ in China, many parts of Europe and South America.

References

References

1. (January 2026). "Wiley Interscience}}{{Dead link".
2. "About Nicoderm CQ & Nicotine Replacement Therapy".
3. "PharmGKB".
4. (August 2024)
5. "10/28/96 READY TO TOSS THOSE CANCER STICKS?".
6. "GlaxoSmithKline: NiQuitin".

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::